©The Author(s) 2025.
World J Gastrointest Endosc. Nov 16, 2025; 17(11): 109157
Published online Nov 16, 2025. doi: 10.4253/wjge.v17.i11.109157
Published online Nov 16, 2025. doi: 10.4253/wjge.v17.i11.109157
Table 4 Rare complications after endoscopic sleeve gastroplasty therapy
| Number | Gender | Age | Initial BMI (kg/m2) | Complication | Timeframe | Adverse reaction | Measures | Symptoms | Ref. |
| 1 | Female | 55 | 44.6 | Stress urinary incontinence, back pain, and nephrolithiasis | During the operation | Dilated bowel loops and acute respiratory failure | High-flow nasal cannula oxygen therapy | Hypoxemia with abdominal distension | [75] |
| 2 | Female | 34 | 30 | None | 1 months | Gallbladder folding secondary to ESG therapy | Laparoscopic cholecystectomy | Hematemesis, somnolence and positive Murphy’s sign | [76] |
| 3 | Female | 31 | Obesity (class I) | None | 2 weeks | Liver abscess | Endoscopic drainage to gastric cavity | Epigastric pain and fever (39.3 °C) | [77] |
| 4 | Female | 53 | NA | None | 1 days | Gastrointestinal symptoms and acute hypoxemic respiratory failure (7 days later) | Remove all sutures on post-op day 1; lovenox, apixaban and other supportive therapy | Refractory nausea, vomiting, abdominal pain, tachycardia and hypertension (BP 160/102 mmHg) | [78] |
| 5 | Female | 40 | NA | None | 1 days | Intestinal obstruction with spontaneous resolution and pulmonary embolism (12 days later) | Apixaban and other supportive therapy | Severe epigastric pain, nausea and vomiting | [78] |
| 6 | Male | 64 | 35.8 | Hypertension, hyperlipidemia, and gastroesophageal reflux disease | 9 hours | Gastric perforation | Exploratory laparotomy | Acute abdominal pain, abdominal distension and respiratory distress | [79] |
| 7 | Male | 53 | 43.6 | None | 1 days | Umbilical hernia-induced small bowel obstruction, pneumoperitoneum and acute kidney injury | Emergent surgery | Abdominal pain, nausea and vomiting | [80] |
| 8 | Among 1000 enrolled patients: 924 (92.4%) experienced medication-controlled nausea or abdominal pain. Overall complication rate: 2.4% (24/1000), comprising: 8 cases of severe abdominal pain requiring intervention, 7 cases of postoperative hemorrhage, 4 cases of perigastric collection with pleural effusion and 5 cases of postoperative fever | [81] | |||||||
- Citation: Zhai YX, Mao T, Li XY, Ren LL, Tian ZB. Advances and future directions in endoscopic bariatric therapies. World J Gastrointest Endosc 2025; 17(11): 109157
- URL: https://www.wjgnet.com/1948-5190/full/v17/i11/109157.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i11.109157